Upadacitinib
| CAS No. | 1310726-60-3 | Cat. No. | BCP19011 |
| Name | Upadacitinib | ||
| Synonyms | ABT494;ABT-494;ABT 494; | ||
| Formula | C17H19F3N6O | M. Wt | 380.1572 |
| Description | Upadacitinib, also known as ABT-494, is a potent and selective JAK inhibitors in development for rheumatoid arthritis. ABT-494 is approximately 74 fold selective for Jak1 over Jak2 in cellular assays dependent on specific, relevant cytokines. ABT-494 demonstrates efficacy in rat arthritis models. Preliminary evidence suggests that compared to tofacitinib, ABT-494 may spare Jak2 and Jak3 dependent signaling. | ||
| Related Products | 1607431-21-9（Upadacitinib tartrate） 2050057-56-0（Upadacitinib hemihydrate） | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase Jak/Stat Pathway Wnt/Stem Cell Epigenetics | ||
| Targets | JAK | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.